64 related articles for article (PubMed ID: 414949)
1. Relevance of the immunoprecipitation assay to human immunogenicity of influenza vaccines.
Brandon FB; Havlick MJ; Shillis JL
Dev Biol Stand; 1977 Jun 1-3; 39():179-85. PubMed ID: 414949
[TBL] [Abstract][Full Text] [Related]
2. [Comparison between killed subunit influenza vaccines and whole virion preparations: study of reactions and protective efficacy in children and adults].
Profeta ML; Bigatello A; Vacchini V; Bramati L; Ferrante P
Boll Ist Sieroter Milan; 1980 Jan; 58(6):457-74. PubMed ID: 6778485
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of influenza vaccine hemagglutinin by immunoelectrophoresis.
Mayner RE; Blackburn RJ; Barry DW
Dev Biol Stand; 1977 Jun 1-3; 39():169-78. PubMed ID: 414948
[TBL] [Abstract][Full Text] [Related]
4. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
[TBL] [Abstract][Full Text] [Related]
6. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G
Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951
[TBL] [Abstract][Full Text] [Related]
7. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
[TBL] [Abstract][Full Text] [Related]
8. Application of an improved single-radial-immunodiffusion technique for the assay of haemagglutinin antigen content of whole virus and subunit influenza vaccines.
Wood JM; Schild GC; Newman RW; Seagroatt V
Dev Biol Stand; 1977 Jun 1-3; 39():193-200. PubMed ID: 414951
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
[TBL] [Abstract][Full Text] [Related]
10. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
[TBL] [Abstract][Full Text] [Related]
11. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
Zuccotti G; Amendola A; Viganò A; Pariani E; Zappa A; Pogliani L; Giacomet V; Savarino A; Podestà A; Rottoli A; Tanzi E; Zanetti A; Radaelli G
Vaccine; 2007 Sep; 25(37-38):6692-8. PubMed ID: 17697730
[TBL] [Abstract][Full Text] [Related]
12. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months.
Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD
Pediatrics; 1982 Apr; 69(4):404-8. PubMed ID: 7070886
[TBL] [Abstract][Full Text] [Related]
13. [Antigenic relationship between influenza A (H3N2) strains circulating in Argentina and vaccine strains].
Savy VL; Baumeister EG; Pontoriero AV
Medicina (B Aires); 1999; 59(3):225-30. PubMed ID: 10451559
[TBL] [Abstract][Full Text] [Related]
14. A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.
Lina B; Fletcher MA; Valette M; Saliou P; Aymard M
Biologicals; 2000 Jun; 28(2):95-103. PubMed ID: 10885616
[TBL] [Abstract][Full Text] [Related]
15. [Safety and immunogenicity of split vaccines of influenza viruses].
Zhu CL; Fang HH; Zhu FC; Wang YQ; Wu XL; Xue FB; Shen YJ; Lian JZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):207-9. PubMed ID: 15640848
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of the immune response to influenza virus subunit vaccines.
Webster RG; Glezen WP; Kasel JA; Laver WG
Dev Biol Stand; 1977 Jun 1-3; 39():243-8. PubMed ID: 604104
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R
Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505
[TBL] [Abstract][Full Text] [Related]
18. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of inactivated H5N2 influenza vaccines against lethal A/Chicken/Queretaro/19/95 infection.
Garcia A; Johnson H; Srivastava DK; Jayawardene DA; Wehr DR; Webster RG
Avian Dis; 1998; 42(2):248-56. PubMed ID: 9645315
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
Beutner KR; Rizzone C; DeMello S; Ogra PL
Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
